ARTICLE | Company News
Curative Biosciences Inc., Inion deal
August 18, 2008 7:00 AM UTC
Curative received an exclusive, worldwide license to develop and commercialize Inion’s N,N-dimethylacetamide (DMA)-based bone growth technology. Inion will receive an undisclosed upfront payment and i...